期刊简介
Hematology Reports (ISSN 2038-8330) 是一个国际化、经同行评审的开放获取期刊。期刊主要发表血液学及相关领域的原创研究、综述、病例报告等文章,研究方向涵盖血液系统疾病的预防、诊断与治疗,以及相关分子与细胞生物学、遗传学、病理生理学、流行病学和临床研究等。期刊致力于为科研工作者提供高效、可靠的学术交流平台,促进血液学领域前沿研究成果的传播。目前期刊已被ESCI、Scopus、PubMed、DOAJ等多个重要数据库收录,最新Impact Factor为1.2,CiteScore为2.3。
期刊scope
• 血友病
• 特发性血小板减少性紫癜
• 淋巴瘤
• 白血病
• 骨髓瘤
• 骨髓增生异常综合征
• 常见血液肿瘤
• 缺铁性贫血
• 再生障碍性贫血
• 地中海贫血
• 深静脉血栓形成
• 肺栓塞
• 免疫性血小板减少症
• 冯维勒布兰德病
• 血液系统恶性肿瘤
• 血红蛋白病
• 输血医学
• 骨髓移植
• 干细胞移植
• 诊断、治疗与护理
• 造血细胞
• 细胞生物学
• 遗传学
• 病理生理学
• 流行病学
• 对照试验研究
期刊主编
Prof. Dr. Claudio Cerchione
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Italy
精选文章
1. A 2024 Update on Menin Inhibitors. A New Class of Target Agents against KMT2A-Rearranged and NPM1-Mutated Acute Myeloid Leukemia
2024年Menin抑制剂更新:针对KMT2A重排及NPM1突变急性髓系白血病的新型靶向药物
Anna Candoni and Gabriele Coppola
2. Survival Outcomes of Patients with Mantle Cell Lymphoma: A Retrospective, 15-Year, Real-Life Study
套细胞淋巴瘤患者生存结局:一项回顾性15年的真实世界研究
Emanuele Cencini et al.
3. Artificial Intelligence (AI) and Drug-Induced and Idiosyncratic Cytopenia: The Role of AI in Prevention, Prediction, and Patient Participation
人工智能 (AI) 与药物诱导及特发性细胞减少症:AI在预防、预测及患者参与中的作用
Emmanuel Andrès et al.
4. Association of Cognitive Impairment with Reduced Health-Related Quality of Life and Depression Among Survivors of Thrombotic Thrombocytopenic Purpura
血栓性血小板减少性紫癜 (TTP) 幸存者认知障碍与健康相关生活质量下降及抑郁的关联性研究
Sruthi Selvakumar et al.
5. Therapeutic Potential of Exportin 1 and Aurora Kinase A Inhibition in Multiple Myeloma Cells
Exportin 1与Aurora激酶A抑制在多发性骨髓瘤细胞中的治疗潜力
Seiichi Okabe et al.
特刊推荐
1. Next-Generation Hematology: Artificial Intelligence and Biomarker-Driven Innovations in Diagnosis and Therapy
下一代血液学:人工智能与基于生物标志物的诊断与治疗创新
Edited by Dr. Ioannis Tsamesidis and Dr. Ilias Pessach
Submission Deadline: 31 October 2026
https://www.mdpi.com/journal/hematolrep/special_issues/4S2J115G36
2. Recent Advances in the Diagnosis and Treatment of Relapsed and Refractory Lymphoid Malignancies
复发及难治性淋巴系统恶性肿瘤的诊断与治疗最新进展
Edited by Dr. John L. Vaughn and Dr. Marc J. Braunstein
Submission Deadline: 30 October 2026
https://www.mdpi.com/journal/hematolrep/special_issues/MIFRZSH400
3. Re-Defining Immune-Mediated Hematological Disorders: Mechanisms and Therapeutic Opportunities
免疫介导性血液疾病的重新定义:机制与治疗机遇
Edited by Dr. Roxane Darbousset and Dr. Julia Kuehn
Submission Deadline: 30 November 2026
https://www.mdpi.com/journal/hematolrep/special_issues/25419WR0QA
4. Myelodysplastic Syndromes: Recent Advances in Biology, Diagnosis, and Treatment
骨髓增生异常综合征:生物学、诊断与治疗的最新进展
Edited by Dr. Krzysztof Mądry, Prof. Dr. Ulrich Germing and Dr. Rafal Machowicz
Submission Deadline: 15 December 2026
https://www.mdpi.com/journal/hematolrep/special_issues/J422F757E7
5. Hemophilia: The Paradigm Shift and the Unresolved Challenges
血友病:范式转变与尚未解决的挑战
Edited by Dr. Felipe Querol
Submission Deadline: 30 September 2026
https://www.mdpi.com/journal/hematolrep/special_issues/4E73VO23W9
作者指南
如您对投稿有任何疑问,欢迎阅读作者指南,或联系 Hematology Reports 期刊编辑部 (hematolrep@mdpi.com)。
https://www.mdpi.com/journal/hematolrep/instructions

转载本文请联系原作者获取授权,同时请注明本文来自MDPI开放科学科学网博客。
链接地址:https://wap.sciencenet.cn/blog-3516770-1539760.html?mobile=1
收藏